Recent Review Finds Missing Data Defining Genetic Mutations Related to Parkinson’s Disease
FotoshopTofs / Pixabay

Recent Review Finds Missing Data Defining Genetic Mutations Related to Parkinson’s Disease

According to a story from Parkinson's News Today, a recent review of Parkinson's disease research found that there is not enough data that explains the link between mutations of several…

Continue Reading Recent Review Finds Missing Data Defining Genetic Mutations Related to Parkinson’s Disease

Researchers are Looking into How RNA Affects Parkinson’s Disease and Psychiatric Disorders

A study carried out by researchers from Harvard Medical School and Brigham and Women’s Hospital has explored the link between dopamine neurones, Parkinson’s disease, and psychiatric disorders. To read about…

Continue Reading Researchers are Looking into How RNA Affects Parkinson’s Disease and Psychiatric Disorders
Use of Canadian Marijuana Approved For Tremor Research
https://pixabay.com/en/marijuana-leaves-cannabis-green-3678222/

Use of Canadian Marijuana Approved For Tremor Research

According to medicalexpress.com, the United States government recently approved the import of marijuana extracts from Canada. Though an uncommon occurrence, the US government approved the import for a clinical trial…

Continue Reading Use of Canadian Marijuana Approved For Tremor Research

New Information Revealed About The Link Between Neurodegenerative Diseases and Aging

According to a story from hms.harvard.edu, a recent study is revealing new information about the connection between aging and neurodegenerative disorders, such as Parkinson's disease, dementia, and amyotrophic lateral sclerosis.…

Continue Reading New Information Revealed About The Link Between Neurodegenerative Diseases and Aging
Two Studies Investigated the Long-Term Effects of Subthalamic Deep Brain Stimulation as a Treatment for Parkinson’s Disease
Skitterphoto / Pixabay

Two Studies Investigated the Long-Term Effects of Subthalamic Deep Brain Stimulation as a Treatment for Parkinson’s Disease

Two studies have looked into the long-term effects of subthalamic deep brain stimulation as a treatment for Parkinson’s disease. For more detailed information on this topic, you can find the…

Continue Reading Two Studies Investigated the Long-Term Effects of Subthalamic Deep Brain Stimulation as a Treatment for Parkinson’s Disease

It Looks Like Drug Developers Will Start Using 23andMe Data to Create New Therapies

According to a story from pcmag.com, the pharmaceutical company GlaxoSmithKline (GSK) has recently partnered with 23andMe as part of a four year long agreement that will grant the company exclusive…

Continue Reading It Looks Like Drug Developers Will Start Using 23andMe Data to Create New Therapies
ICYMI: Recruitment Has Begun For a Phase I Clinical Trial of A Drug Designed to Treat Parkinsonian Diseases
qimono / Pixabay

ICYMI: Recruitment Has Begun For a Phase I Clinical Trial of A Drug Designed to Treat Parkinsonian Diseases

Prana Biotechnology has announced that it has begun recruiting healthy volunteers for its Phase I clinical trial of the experimental drug PBT434. The drug is thought to affect processes linked…

Continue Reading ICYMI: Recruitment Has Begun For a Phase I Clinical Trial of A Drug Designed to Treat Parkinsonian Diseases
The First Patient Has Been Dosed in the Third Cohort of a Phase I Trial For a Potential Parkinson’s Disease Treatment
ColiN00B / Pixabay

The First Patient Has Been Dosed in the Third Cohort of a Phase I Trial For a Potential Parkinson’s Disease Treatment

The first patient has undergone stem cell transplant treatment in the third cohort of a Phase I clinical study of the experimental treatment ISC-hpNSC for Parkinson’s disease. The full article can…

Continue Reading The First Patient Has Been Dosed in the Third Cohort of a Phase I Trial For a Potential Parkinson’s Disease Treatment